• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • English
    • Español (Spanish)
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

Hide Search
Shopping Cart
Show SearchSearch
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
    • Our Impact
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
    • Interactive Tool
    • Other Educational Tools
    • LactRx App
  • Studies
    • Ongoing Studies
    • What’s Involved?
    • Join Now
    • Refer a Patient
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
  • Donate
  • Contact
  • Show SearchSearch

Showing 9–14 of 14 results

  • BOOSTRIX Vaccine in Pregnancy Study Flyer

    BOOSTRIX Vaccine in Pregnancy Study Flyer

    A double-sided, bilingual (English and Spanish) flyer for patients that covers the Boostrix Tdap Vaccine Pregnancy Study. (8.5 x 11in)

    Clear
  • MotherToBaby California Patient Referral Card

    MotherToBaby California Patient Referral Card

    Referral cards that healthcare providers can give to patients to share contact information for MotherToBaby’s observational pregnancy studies. Available in English and Spanish. (3.5 x 2in)

    Clear
  • Patient Referral Card

    Patient Referral Card

    Referral cards for patients that share contact information for MotherToBaby’s observational pregnancy studies. Available in English and Spanish. (3.5 x 2in)

    Clear
  • Patient Referral Tear Pads

    Patient Referral Tear Pads

    Tear pads for healthcare providers. Each tear pad includes 25 sheets that can be given out to patients interested in MotherToBaby’s observational pregnancy studies. Specialty-specific tear pads are also available for the following: Allergists & Immunologists, Dermatologists, Gastroenterologists, Neurologists, and Rheumatologists. (3.5 x 5in)

    Clear
  • Pregnancy Studies FAQ

    Pregnancy Studies FAQ

    A flyer for patients that covers common questions and the process of participating MotherToBaby’s observational pregnancy studies. Available in English and Spanish. Available in shrink-wrapped packs of 50, please specify the total number of flyers requested (If you are requesting 2 packs of 50 write ‘100’ below). (8.5 x 11in)

    Clear
  • Lead Exposure Rack Card – PDF

    Lead Exposure Rack Card – PDF

    A double-sided rack card that provides information on lead exposure during pregnancy and breastfeeding. One side is titled ‘Facts for Families,’ while the other is labeled ‘Facts for Professionals. (3.75 x 8.5in)
    PDF, download only

    Clear
  • « Previous Page
  • 1
  • 2

Footer

               

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Constipation
  • Coronavirus (COVID-19)
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Lupus
  • Multiple Sclerosis
  • Non-Radiographic Axial Spondyloarthritis
  • Psoriasis
  • Psoriatic Arthritis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists

Copyright © 2025 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.